1. Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis. Issue 10 (October 2016) Authors: Moran, Sebastian; Martínez-Cardús, Anna; Sayols, Sergi; Musulén, Eva; Balañá, Carme; Estival-Gonzalez, Anna; Moutinho, Cátia; Heyn, Holger; Diaz-Lagares, Angel; de Moura, Manuel Castro; Stella, Giulia M; Comoglio, Paolo M; Ruiz-Miró, Maria; Matias-Guiu, Xavier; Pazo-Cid, Roberto; Antón, Antonio; ... Journal: Lancet oncology Issue: Volume 17:Issue 10(2016:Oct.) Page Start: 1386 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Issue 10294 (3rd July 2021) Authors: Janjigian, Yelena Y; Shitara, Kohei; Moehler, Markus; Garrido, Marcelo; Salman, Pamela; Shen, Lin; Wyrwicz, Lucjan; Yamaguchi, Kensei; Skoczylas, Tomasz; Campos Bragagnoli, Arinilda; Liu, Tianshu; Schenker, Michael; Yanez, Patricio; Tehfe, Mustapha; Kowalyszyn, Ruben; Karamouzis, Michalis V; Brug... Journal: Lancet Issue: Volume 398:Issue 10294(2021) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Gemcitabine–erlotinib versus gemcitabine–erlotinib–capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group. (April 2017) Authors: Irigoyen, Antonio; Gallego, Javier; Guillén Ponce, Carmen; Vera, Ruth; Iranzo, Vega; Ales, Inmaculada; Arévalo, Sara; Pisa, Aleydis; Martín, Marta; Salud, Antonieta; Falcó, Esther; Sáenz, Alberto; Manzano Mozo, José Luis; Pulido, Gema; Martínez Galán, Joaquina; Pazo-Cid, Roberto; Rivera, Fernando... Journal: European journal of cancer Issue: Volume 75(2017) Page Start: 73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Liposomal Doxorubicin in the Treatment of Breast Cancer Patients: A Review. (25th March 2013) Authors: Lao, Juan; Madani, Julia; Puértolas, Teresa; Álvarez, María; Hernández, Alba; Pazo-Cid, Roberto; Artal, Ángel; Antón Torres, Antonio Other Names: Caraglia Michele Academic Editor. Journal: Journal of drug delivery Issue: Volume 2013(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study. (March 2020) Authors: Philip, Philip A; Lacy, Jill; Portales, Fabienne; Sobrero, Alberto; Pazo-Cid, Roberto; Manzano Mozo, José L; Kim, Edward J; Dowden, Scot; Zakari, Ahmed; Borg, Christophe; Terrebonne, Eric; Rivera, Fernando; Sastre, Javier; Bathini, Venu; López-Trabada, Daniel; Asselah, Jamil; Saif, Muhammad Wasif... Journal: Lancet gastroenterology and hepatology Issue: Volume 5:Number 3(2020) Page Start: 285 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. TRAIL-coated lipid-nanoparticles overcome resistance to soluble recombinant TRAIL in non-small cell lung cancer cells. (22nd March 2016) Authors: De Miguel, Diego; Gallego-Lleyda, Ana; Ayuso, José María; Erviti-Ardanaz, Sandra; Pazo-Cid, Roberto; del Agua, Celia; Fernández, Luis José; Ochoa, Ignacio; Anel, Alberto; Martinez-Lostao, Luis Journal: Nanotechnology Issue: Volume 27:Number 18(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗